PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Negative revenue growth while MCHP stands at 10.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-58.24%
Negative gross profit growth while MCHP is at 15.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
250.00%
EBIT growth above 1.5x MCHP's 140.04%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
250.00%
Operating income growth above 1.5x MCHP's 132.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
147.06%
Net income growth above 1.5x MCHP's 87.97%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
148.23%
EPS growth above 1.5x MCHP's 70.34%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
148.23%
Diluted EPS growth above 1.5x MCHP's 70.34%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-29.30%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-29.30%
Reduced diluted shares while MCHP is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
53.23%
Dividend growth above 1.5x MCHP's 10.17%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-97.71%
Negative OCF growth while MCHP is at 33.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-130.90%
Negative FCF growth while MCHP is at 34.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
85.05%
10Y revenue/share CAGR above 1.5x MCHP's 51.09%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
69.30%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
41.60%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
484.92%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-31.93%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-36.89%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
158.20%
Similar 5Y dividend/share CAGR to MCHP's 175.02%. Walter Schloss sees parallel philosophies in mid-term capital returns.
139.08%
3Y dividend/share CAGR above 1.5x MCHP's 81.65%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
0.22%
AR growth is negative/stable vs. MCHP's 10.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
1.84%
We show growth while MCHP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-6.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
37.76%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-11.77%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-9.17%
We cut SG&A while MCHP invests at 4.80%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.